General Information


Congress Venue

Rydges Melbourne
186 Exhibition Street
Melbourne VIC 3000
Australia

The 4th Annual Lysosomal Disease Summit will take place at Rydges Melbourne, in Melbourne’s central business district.


Registration

Registration will open 1 April 2026.


Abstract Submission

Abstract submissions will open 1 April 2026.


Dates

2-3 October 2026


Language

The official language of the Summit is English.


Summit Materials and Name Badge

You will receive the Summit’s printed material and your name badge at the registration desk. Please wear your name badge at all times during the Summit and to all official events.


Visas

Participants from certain countries may require a visa to travel to Australia. They are requested to check with their local Australian Consulate/Embassy well in advance of their travel date. It is the participant’s responsibility to obtain a visa as necessary.


Visa Letters

Official letters of invitation designed to assist with obtaining an entry visa can be created upon registering for the Summit. The registration confirmation email will contain a link for participants to request an invitation letter containing the following:

Conference Name
Attendee Title (Mr./Ms./Dr./Prof.)
Full Name (as it appears in your passport)
Complete Mailing Address
Passport Number

Please note that such letters do not represent a commitment by the Summit Organizer to provide any financial assistance.


Audience

The Summit is intended for researchers, clinicians, and other professionals interested in lysosomal diseases. The content for this event is not targeted to patients and families.


Continuing Professional Development (CPD) Certificate

This summit will be run independently of an Australian CPD home. However, attendees planning to self-record a CPD activity with the CPD home related to their practice will be required to complete a course evaluation. Upon completion of the summit, attendees may download/print a certificate confirming their involvement in the Summit. The certificate can be used in the case of a future CPD audit.

This Education Activity will provide CPD; the total number of CPD credits will be determined once the agenda is finalized.


CPD-Eligible Educational Activity

The Lysosomal Disease Summit is committed to providing learners with high-quality, CPD-eligible educational activities that promote improvements or quality in healthcare and are not a specific proprietary business interest of any commercial interest or sponsoring company.

To achieve fairness and balance in the educational activity, sponsors and exhibitors shall have no control over: 

  1. Evaluation of the activity
  2. Identification of CPD needs
  3. Determination of educational objectives
  4. Selection and presentation of content
  5. Selection of speakers or persons who will be in a position to control the content of the educational activity

CPD Learning Outcomes

At the completion of this program, the participant should be able to:

  • Describe current and emerging diagnostic testing available for people living with lysosomal diseases.
  • Identify therapies currently available to individuals living with lysosomal diseases, and emerging therapies under investigation.
  • Discuss long-term outcomes of approved therapies.
  • Summarize the current challenges for people diagnosed with lysosomal diseases in Australia and surrounding countries.
  • Recognize the unmet needs of each lysosomal disease being discussed.
  • Formulate new research ideas for these lysosomal diseases.

Liability & Insurance

The Summit organizers cannot accept any liability for personal accidents or loss of/damage to private property of participants of the Lysosomal Disease Summit.


Dress Code

The dress code is informal for all occasions.


Summit Sponsorships

Summit Sponsorship sales are open. Please contact Josefine Scott at jscott@etherio.com to request a Sponsorship Prospectus.


Summit Logistics

Josefine Scott
jscott@etherio.com


Previous Lysosomal Disease Summit Content


Acknowledgment

We respectfully acknowledge the Traditional Owners of the land on which the Lysosomal Disease Summit will take place, the Wurundjeri Woi Wurrung people of the Kulin Nation, and pay our respects to their Elders past and present. We recognise their continuing connection to land, waters, and culture.